SPIORAD MEDICAL LIMITED

Spiorad Medical is an Irish‑based innovator dedicated to simplifying the closure of large‑bore femoral artery access sites (12‑24 F). By marrying cutting‑edge medical intervention with device innovation, the company delivers a user‑friendly vascular closure solution that aims to improve clinical outcomes and accelerate patient recovery after complex interventional procedures.

The core offering is a specialised closure device designed specifically for large French femoral access, addressing a recognised gap in the market. Spiorod’s technology is backed by extensive clinical insight from its co‑founders – CEO Judi O’Malley, a former clinical vascular physiologist with commercial experience at Medtronic, Abbott and J&J, and CMO Dr Samer Arnous, a consultant interventional cardiologist with over two decades of experience in coronary and structural heart interventions across Ireland, the UK and Europe. Their combined expertise ensures the product is both technically robust and aligned with the practical needs of interventionalists.

Spiorad Medical serves interventional cardiology and vascular teams seeking reliable, efficient closure of large‑bore femoral access, positioning itself as a patient‑centred, commercially driven partner in the Irish and broader European healthcare landscape.